Pancreatic Cancer Research

ResearcherUniversity of Nebraska Medical CenterNo recent work listed

Mohammad I. Awaji

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3543-383X; OpenAlex author ID A5045865672. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2018: 1 paper · 2019: 1 paper · 2020: 1 paper

Papers 3

  1. CXCR2 signaling promotes secretory cancer-associated fibroblasts in pancreatic ductal adenocarcinoma. Co-author DOI 10.1096/fj.201902990r↗
  2. Cancer-Associated Fibroblasts' Functional Heterogeneity in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers11030290↗
  3. Pathological and functional significance of Semaphorin-5A in pancreatic cancer progression and metastasis. Co-author DOI 10.18632/oncotarget.23644↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Rakesh K. Singh · 3 shared papers, 2018–2020 · strength 0.38
  2. Abhilasha Purohit · 2 shared papers, 2018–2020 · strength 0.18
  3. Sugandha Saxena · 2 shared papers, 2018–2020 · strength 0.18
  4. Surinder K. Batra · 2 shared papers, 2018–2020 · strength 0.18
  5. Satyanarayana Rachagani · 2 shared papers, 2018–2020 · strength 0.18
  6. Dipakkumar R. Prajapati · 1 shared paper, 2020 · strength 0.10
  7. Maneesh Jain · 1 shared paper, 2020 · strength 0.10
  8. Sushil Kumar K · 1 shared paper, 2020 · strength 0.10
  9. Pranita Atri · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.